MX356649B - Sistema de liberación permeante y métodos para su uso. - Google Patents

Sistema de liberación permeante y métodos para su uso.

Info

Publication number
MX356649B
MX356649B MX2015004319A MX2015004319A MX356649B MX 356649 B MX356649 B MX 356649B MX 2015004319 A MX2015004319 A MX 2015004319A MX 2015004319 A MX2015004319 A MX 2015004319A MX 356649 B MX356649 B MX 356649B
Authority
MX
Mexico
Prior art keywords
permeant
subject
matrix
methods
conduits
Prior art date
Application number
MX2015004319A
Other languages
English (en)
Inventor
Smith Alan
Eppstein Jonathan
Enscore David
Tagliaferri Frank
Tolia Gaurav
Chang Shulun
Patel Yogi
Mcrae Stuart
Original Assignee
Nitto Denko Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nitto Denko Corp filed Critical Nitto Denko Corp
Publication of MX356649B publication Critical patent/MX356649B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Abstract

La presente invención se refiere a un dispositivo para causar el flujo transdérmico de un permeante en un sujeto vía al menos una ruta formada a través dela capa dela piel del sujeto, que comprende: un depósito de liberación que comprende: i) una matriz no biodegradable que tiene una superficie inferior y definiendo una pluralidad de conductos en la matriz, al menos una porción de la pluralidad de conductos estando en comunicación con la superficie inferior; y ii) un permeante hidrofílico no disuelto se coloca en la misma en al menos una porción de la pluralidad de conductos dela matriz, en donde el permeante hidrofílico puede llegar a estar en contacto con el fluido subcutáneo del sujeto cuando la superficie inferior de la matriz está en posición en comunicación fluida con al menos una ruta formada, una capa de soporte de apoyo semi-permeable proporciona una proporción de transmisión de vapor promedio específica para controlar una proporción de un transporte de fluido, y el dispositivo es caracterizado porque el permeante hidrofílico comprende al menos un agente bioactivo y al menos un relleno biocompatible, en donde al menos un relleno biocompatible puede contar para 30% en peso a 80% en peso del depósito de liberación.
MX2015004319A 2005-06-17 2006-06-19 Sistema de liberación permeante y métodos para su uso. MX356649B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69189805P 2005-06-17 2005-06-17
PCT/US2006/023640 WO2006138658A2 (en) 2005-06-17 2006-06-19 Permeant delivery system and methods for use thereof

Publications (1)

Publication Number Publication Date
MX356649B true MX356649B (es) 2018-06-07

Family

ID=37571260

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015004319A MX356649B (es) 2005-06-17 2006-06-19 Sistema de liberación permeante y métodos para su uso.

Country Status (14)

Country Link
US (1) US20070031495A1 (es)
EP (2) EP3311762B1 (es)
JP (3) JP5717316B2 (es)
CN (1) CN101262824B (es)
AU (1) AU2006261325B2 (es)
CA (2) CA2612511C (es)
ES (1) ES2667943T3 (es)
HK (1) HK1253408A1 (es)
IL (1) IL188145A0 (es)
IN (1) IN2015DN01758A (es)
MX (1) MX356649B (es)
SG (1) SG172736A1 (es)
TW (1) TWI419717B (es)
WO (1) WO2006138658A2 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003226605A1 (en) 2002-04-19 2003-11-03 Transpharma Medical Ltd. Handheld transdermal drug delivery and analyte extraction
US8016811B2 (en) * 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
EP1888001B1 (en) * 2005-06-10 2014-08-06 Syneron Medical Ltd. Patch for transdermal drug delivery
EP2029218B1 (en) 2006-06-15 2019-08-14 PolyPharma Pty Ltd A delivery system
JP2009543902A (ja) 2006-07-10 2009-12-10 メディパックス インコーポレイテッド 超弾性エポキシヒドロゲル
US8169122B1 (en) * 2006-12-15 2012-05-01 Dxna Llc Ultra sonic release of DNA or RNA
US7713196B2 (en) * 2007-03-09 2010-05-11 Nellcor Puritan Bennett Llc Method for evaluating skin hydration and fluid compartmentalization
EP2200666B1 (en) * 2007-10-09 2014-12-03 Syneron Medical Ltd. Magnetic patch coupling
EP2205967B1 (en) * 2007-10-17 2013-05-01 Syneron Medical Ltd. Dissolution rate verification
CA2704164A1 (en) * 2007-10-29 2009-05-07 Transpharma Medical Ltd. Vertical patch drying
JP2011505520A (ja) 2007-12-03 2011-02-24 メディパックス インコーポレイテッド 流体計量供給装置
AU2008332738B2 (en) 2007-12-05 2013-08-15 Syneron Medical Ltd. A disposable electromagnetic energy applicator and method of using it
NZ604092A (en) * 2008-03-31 2015-08-28 Nitto Denko Corp Permeant delivery system and methods for use thereof
US8606366B2 (en) 2009-02-18 2013-12-10 Syneron Medical Ltd. Skin treatment apparatus for personal use and method for using same
US9238102B2 (en) 2009-09-10 2016-01-19 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US20110172637A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Drug delivery device including tissue support structure
US20110172639A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Device and method for delivery of microneedle to desired depth within the skin
US20110172645A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Wearable drug delivery device including integrated pumping and activation elements
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
EP2567728A4 (en) * 2010-05-01 2014-04-23 Optnics Prec Co Ltd PERCUTANEOUS DELIVERY DEVICE AND PRODUCTION METHOD THEREOF
JP5887041B2 (ja) 2010-08-02 2016-03-16 ウェイト、ブレント、エル． ポリメラーゼ連鎖反応のための加圧可能なカートリッジ
WO2012061556A1 (en) 2010-11-03 2012-05-10 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
WO2013138524A1 (en) 2012-03-14 2013-09-19 Medipacs, Inc. Smart polymer materials with excess reactive molecules
JP6243102B2 (ja) * 2012-05-01 2017-12-06 株式会社ジェムインターナショナル 貼付剤
JP2016518932A (ja) * 2013-05-06 2016-06-30 ミューファーマ ピーティーワイ リミテッド 非侵襲的薬剤アプリケータ
US20170056637A1 (en) * 2014-05-06 2017-03-02 Mupharma Pty Ltd Non-invasive agent applicator
EP3338853A1 (en) * 2016-12-23 2018-06-27 Sanofi-Aventis Deutschland GmbH Medicament delivery device
CN114286706A (zh) * 2019-06-28 2022-04-05 帕斯帕特技术有限公司 用于通过身体皮肤递送药物的方法和系统
WO2020264026A1 (en) 2019-06-28 2020-12-30 Passport Technologies, Inc. Triptan microporation delivery system
WO2023240203A1 (en) * 2022-06-10 2023-12-14 Passport Technologies, Inc. Transdermal delivery device for peptide delivery and methods of use

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262564A (en) * 1983-09-01 1989-10-31 Minoru Sasaki Iontophoresis device
FR2562800A1 (fr) * 1984-04-11 1985-10-18 Fournier Laboratoires Dispositif pour l'administration percutanee de medicaments
US5032109A (en) * 1987-02-10 1991-07-16 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US4915950A (en) * 1988-02-12 1990-04-10 Cygnus Research Corporation Printed transdermal drug delivery device
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
JP3053913B2 (ja) * 1991-07-15 2000-06-19 帝三製薬株式会社 ビンポセチン類含有貼付剤
US5462743A (en) * 1992-10-30 1995-10-31 Medipro Sciences Limited Substance transfer system for topical application
US6377847B1 (en) * 1993-09-30 2002-04-23 Vyteris, Inc. Iontophoretic drug delivery device and reservoir and method of making same
US5885211A (en) * 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
PT1563788E (pt) * 1995-08-29 2015-06-02 Nitto Denko Corp Microporação de pele humana para distribuição de fármaco e aplicações de monitorização
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
DK0921840T3 (da) * 1996-07-03 2003-09-22 Altea Therapeutics Corp Multipel mekanisk mikroperforering af hud eller slimhinde
CN2274962Y (zh) * 1996-08-28 1998-02-25 林平 防渗透皮药贴
US6527716B1 (en) 1997-12-30 2003-03-04 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
JP4182555B2 (ja) * 1997-11-21 2008-11-19 株式会社ポリトロニクス イオントフォレシス型の経皮投薬用素子
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
US6022316A (en) * 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
US6148232A (en) * 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
US6597946B2 (en) * 1998-11-09 2003-07-22 Transpharma Ltd. Electronic card for transdermal drug delivery and analyte extraction
US6708060B1 (en) 1998-11-09 2004-03-16 Transpharma Ltd. Handheld apparatus and method for transdermal drug delivery and analyte extraction
US20050191337A1 (en) * 1999-03-31 2005-09-01 L'oreal S.A. Patch with a magnetic field effect
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
ATE324922T1 (de) * 1999-06-08 2006-06-15 Altea Therapeutics Corp Vorrichtung zur mikroporation eines biologischen gewebes mittels einer filmgewebe schnittstellenvorrichtung und verfahren
US20030078499A1 (en) * 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
US20020131994A1 (en) * 2001-01-10 2002-09-19 Schur Henry B. Non-irritating formulation for the transdermal delivery of substances
US6597794B2 (en) 2001-01-23 2003-07-22 Hewlett-Packard Development Company, L.P. Portable electronic device having an external speaker chamber
CA2440884C (en) * 2001-03-16 2012-05-22 Alza Corporation Transdermal patch for administering fentanyl
JP2002282371A (ja) * 2001-03-28 2002-10-02 Polytronics Ltd 低電圧駆動型イオントフォレシス素子
US7083580B2 (en) * 2001-04-06 2006-08-01 Mattioli Engineering Ltd. Method and apparatus for skin absorption enhancement and transdermal drug delivery
JP2003128536A (ja) * 2001-10-25 2003-05-08 Kenji Sugibayashi 温熱処理と併用する経皮吸収製剤
DE10159745A1 (de) * 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
ES2701884T3 (es) * 2002-03-11 2019-02-26 Nitto Denko Corp Sistema de parche de administración transdérmica de fármacos
US6945952B2 (en) * 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
JP2004202086A (ja) * 2002-12-26 2004-07-22 Teikoku Seiyaku Co Ltd エレクトロポレーション用薬物投与部、エレクトロポレーション用薬物投与システム、及びエレクトロポレーション用薬物投与方法
EP1641441B1 (en) * 2003-04-30 2014-03-12 Purdue Pharma L.P. Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
US8016811B2 (en) * 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
GB2414675B (en) * 2004-06-05 2006-09-06 Dewan Fazlul Hoque Chowdhury Transdermal drug delivery device
WO2006015299A2 (en) * 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing

Also Published As

Publication number Publication date
HK1253408A1 (zh) 2019-06-14
EP3311762B1 (en) 2020-07-22
CA2612511C (en) 2014-08-12
EP3311762A1 (en) 2018-04-25
TWI419717B (zh) 2013-12-21
JP6165184B2 (ja) 2017-07-19
AU2006261325B2 (en) 2013-01-10
EP1906846A4 (en) 2012-12-19
AU2006261325A1 (en) 2006-12-28
WO2006138658A3 (en) 2007-03-01
SG172736A1 (en) 2011-07-28
JP6692761B2 (ja) 2020-05-13
ES2667943T3 (es) 2018-05-16
IN2015DN01758A (es) 2015-05-29
EP1906846A2 (en) 2008-04-09
CA2852537C (en) 2019-07-23
JP2008543872A (ja) 2008-12-04
CN101262824A (zh) 2008-09-10
CA2852537A1 (en) 2006-12-28
EP1906846B1 (en) 2018-03-21
CN101262824B (zh) 2011-06-29
IL188145A0 (en) 2008-03-20
JP2017113579A (ja) 2017-06-29
CA2612511A1 (en) 2006-12-28
TW200714300A (en) 2007-04-16
JP2015128599A (ja) 2015-07-16
US20070031495A1 (en) 2007-02-08
WO2006138658A2 (en) 2006-12-28
JP5717316B2 (ja) 2015-05-13

Similar Documents

Publication Publication Date Title
MX356649B (es) Sistema de liberación permeante y métodos para su uso.
SMP200900075B (it) Dispositivi terapeutici ibridi impiantabli.
HK1101341A1 (en) Dressing for a wound
TW200628175A (en) Transdermal drug delivert device including an occlusive backing
MX2009012273A (es) Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
DK1841491T3 (da) Transdermalt lægemiddeludleveringsapparat
WO2008011625A3 (en) Microneedle devices and methods of drug delivery or fluid withdrawal
CA2474742A1 (en) Dermal access member
PE20001390A1 (es) Articulo absorbente con mejor combinacion de sensacion de suavidad para la piel y manejo fluido
EP2289574A3 (en) Medical devices and methods of making medical devices
EP1471953A4 (en) GAS PRESSURE ACTIVATED MICROWAVE ARRANGEMENTS, SYSTEMS AND METHODS RELATING THERETO
CA2949821C (en) Self contained wound dressing with micropump
WO2007041314A3 (en) Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
WO2005091852A3 (en) Multilayered transdermal drug delivery device
WO2008024141A8 (en) Nanofiber structures on asperities for sequestering, carrying and transferring substances
LT2529732T (lt) Transderminė terapinė sistema su lipniu sluoksniu, sistemos išorinio sluoksnio silikonavimo būdas ir išorinio sluoksnio panaudojimas
PL1684846T3 (pl) Urządzenie do transdermalnego podawania substancji czynnych
WO2008005458A3 (en) Delivery device having self-assembling dendritic polymers and method of use thereof
WO2008009925A3 (en) Hydrogen peroxide delivery system
AR072492A1 (es) Dispositivo y administracion transdermica de estrogeno
WO2008043017A3 (en) Vascular access devices including a tear-resistant septum
PL1895994T3 (pl) Wielowarstwowy system podawania leków z barierą zabezpieczającą przed wypływaniem materiału ze zbiornika
WO2008039319A3 (en) Injection of therapeutic into porous regions of a medical device
WO2009039429A3 (en) Therapeutic agent-eluting medical devices having textured polymeric surfaces
WO2008007098A3 (en) Drug delivery polymer with hydrochloride salt of clindamycin